Cardinal Health, Inc. $CAH Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 10.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,228,855 shares of the company’s stock after selling 137,627 shares during the period. ProShare Advisors LLC owned about 0.51% of Cardinal Health worth $206,448,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Stratos Wealth Partners LTD. raised its position in Cardinal Health by 25.0% in the first quarter. Stratos Wealth Partners LTD. now owns 7,588 shares of the company’s stock valued at $1,046,000 after purchasing an additional 1,519 shares during the period. Allworth Financial LP boosted its holdings in shares of Cardinal Health by 5.5% in the first quarter. Allworth Financial LP now owns 3,978 shares of the company’s stock valued at $540,000 after acquiring an additional 207 shares during the period. Ballentine Partners LLC boosted its stake in shares of Cardinal Health by 66.7% during the first quarter. Ballentine Partners LLC now owns 6,145 shares of the company’s stock worth $847,000 after buying an additional 2,459 shares during the period. New York State Common Retirement Fund boosted its holdings in shares of Cardinal Health by 2.2% in the first quarter. New York State Common Retirement Fund now owns 331,748 shares of the company’s stock valued at $45,705,000 after acquiring an additional 7,072 shares in the last quarter. Finally, Stephens Inc. AR raised its stake in shares of Cardinal Health by 5.6% during the 1st quarter. Stephens Inc. AR now owns 6,195 shares of the company’s stock worth $853,000 after buying an additional 329 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH opened at $203.40 on Monday. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $203.67. The firm has a 50 day moving average price of $160.02 and a 200 day moving average price of $156.87. The company has a market cap of $48.33 billion, a PE ratio of 31.53, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the previous year, the firm earned $1.88 earnings per share. Cardinal Health’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is 30.77%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Argus increased their price objective on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Leerink Partners upped their price target on shares of Cardinal Health from $187.00 to $211.00 in a research note on Friday, October 31st. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Citigroup upped their target price on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Finally, Evercore ISI lifted their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $205.00.

Insider Buying and Selling

In other news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last quarter. Company insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.